Cargando…

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation

Detalles Bibliográficos
Autores principales:	Mani, Helen, Douxfils, Jonathan, Ansell, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452797/ https://www.ncbi.nlm.nih.gov/pubmed/26078954 http://dx.doi.org/10.1155/2015/549803

Ejemplares similares

Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations
por: Douxfils, Jonathan, et al.
Publicado: (2015)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Perioperative management of patients on direct oral anticoagulants
por: Dubois, Virginie, et al.
Publicado: (2017)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

In Search of Safe and Effective Oral Anticoagulation
por: Curtiss, Frederic R.
Publicado: (2005)

Novel antidotes for target specific oral anticoagulants
por: Das, Arundhati, et al.
Publicado: (2015)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
por: Lessire, Sarah, et al.
Publicado: (2016)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
por: Ansell, Jack
Publicado: (2017)

New oral anticoagulants: discussion on monitoring and adherence should start now!
por: ten Cate, Hugo
Publicado: (2013)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Cancer‐associated thrombosis: Role of direct oral anticoagulants
por: Ikeda, Masataka, et al.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Transvenous lead extraction on continued oral anticoagulation
por: Burri, Haran
Publicado: (2021)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Expanding use of new oral anticoagulants
por: Weitz, Jeffrey I.
Publicado: (2014)

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays
por: Douxfils, Jonathan, et al.
Publicado: (2014)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban
por: DiNicolantonio, James J, et al.
Publicado: (2014)

How to Overcome Social Inequalities of Oral Anticoagulation Usage in Korea?
por: Lee, Ki Hong
Publicado: (2020)

Results expression for tests used to measure the anticoagulant effect of new oral anticoagulants
por: Tripodi, Armando
Publicado: (2013)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Oral Anticoagulants: A Cost-Effectiveness Approach
por: Stamp, E. J., et al.
Publicado: (1985)

Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants
por: Sarah, Lessire, et al.
Publicado: (2014)

Prescribing patterns of target-specific oral anticoagulants: an academic hospital perspective
por: Johnson, Stacy A., et al.
Publicado: (2015)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
por: Gallagher, Celine, et al.
Publicado: (2019)

Beyond warfarin: The advent of new oral anticoagulants
por: Laroia, Sandeep T, et al.
Publicado: (2015)

New oral anticoagulants – a practical guide
por: Ciurus, Tomasz, et al.
Publicado: (2015)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Coagulation assessment with the new generation of oral anticoagulants
por: Pollack, Charles V
Publicado: (2016)

The new era of anticoagulation
por: Anklesaria, Zafia, et al.
Publicado: (2016)

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
por: Blann, Andrew
Publicado: (2015)

Benefit, Risk and Cost in Oral Anticoagulation for Stroke Prevention: Is It the Third Factor?
por: Choi, Jong-Il
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n1f8a4g41vte4i8dmvv99dabah